We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$52.9B
AUM Growth
-$871M
Cap. Flow
-$305M
Cap. Flow %
-0.58%
Top 10 Hldgs %
10.68%
Holding
4,294
New
780
Increased
1,199
Reduced
1,223
Closed
1,034

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$412M
2
PFE icon
Pfizer
PFE
+$283M
3
DVN icon
Devon Energy
DVN
+$194M
4
VLO icon
Valero Energy
VLO
+$187M
5
MO icon
Altria Group
MO
+$174M

Sector Composition

Rank Sector Weight
1 Healthcare 15.04%
2 Energy 12.07%
3 Financials 9.11%
4 Consumer Discretionary 8.85%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIV icon
976
Telefônica Brasil
VIV
$18.3B
$9.99M 0.02%
716,874
+397,972
+125% +$5.92M
AGU
977
DELISTED
Agrium
AGU
$9.98M 0.02%
94,230
+61,080
+184% +$6.43M
CEO
978
DELISTED
CNOOC Limited
CEO
$9.98M 0.02%
70,311
+48,993
+230% +$7.74M
WBD icon
979
PUT
Warner Bros
WBD
$72B
$9.98M 0.02%
+300,000
New +$9.89M
MTW icon
980
Manitowoc
MTW
$710M
$9.98M 0.02%
561,968
+235,302
+72% +$4.29M
TARO
981
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$9.93M 0.02%
69,119
-104,872
-60% -$15M
BPFH
982
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$9.92M 0.02%
739,623
-561,215
-43% -$7.19M
KPTI icon
983
Karyopharm Therapeutics
KPTI
$42.2M
$9.92M 0.02%
24,297
+17,889
+279% +$7.73M
KLIC icon
984
Kulicke & Soffa
KLIC
$4.37B
$9.88M 0.02%
843,815
+323,251
+62% +$4.49M
ATI icon
985
ATI
ATI
$28.6B
$9.87M 0.02%
326,957
-474,217
-59% -$15.7M
VVC
986
DELISTED
Vectren Corporation
VVC
$9.87M 0.02%
256,446
-65,555
-20% -$2.77M
TRAK
987
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
$9.86M 0.02%
157,029
+79,203
+102% +$3.53M
CMCSA icon
988
Comcast
CMCSA
$95.9B
$9.86M 0.02%
327,822
-1,476,908
-82% -$43.4M
PXD
989
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
$9.85M 0.02%
71,000
IFF icon
990
International Flavors & Fragrances
IFF
$21.9B
$9.84M 0.02%
90,016
-72,314
-45% -$8.35M
B
991
DELISTED
Barnes Group Inc.
B
$9.8M 0.02%
251,469
+48,666
+24% +$1.96M
KGC icon
992
Kinross Gold
KGC
$39.1B
$9.79M 0.02%
4,219,738
-1,286,782
-23% -$3.07M
FNBC
993
DELISTED
First NBC Bank Holding Company
FNBC
$9.78M 0.02%
271,709
+215,747
+386% +$7.55M
SSTK icon
994
Shutterstock
SSTK
$198M
$9.78M 0.02%
166,803
+146,144
+707% +$9.55M
RIGP
995
DELISTED
Transocean Partners LLC
RIGP
$9.77M 0.02%
706,618
-218,485
-24% -$3.24M
ICUI icon
996
ICU Medical
ICUI
$4.57B
$9.75M 0.02%
101,902
-89,664
-47% -$8.38M
ADT
997
DELISTED
ADT Corp
ADT
$9.74M 0.02%
290,279
+85,698
+42% +$3.26M
CUZ icon
998
Cousins Properties
CUZ
$4.94B
$9.74M 0.02%
+332,328
New +$9.56M
NSP icon
999
Insperity
NSP
$1.99B
$9.73M 0.02%
382,304
+41,712
+12% +$1.09M
EFOR
1000
Everforth Inc
EFOR
$1.33B
$9.71M 0.02%
247,113
+66,979
+37% +$2.56M

Similar funds

Israel Englander's Q2 2015 Portfolio in Review

As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.

  • Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
  • Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
  • Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
  • Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
  • Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
  • Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
  • Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.